Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 26 04:00PM ET
1.21
Dollar change
+0.02
Percentage change
1.68
%
Index- P/E- EPS (ttm)-0.13 Insider Own0.45% Shs Outstand408.55M Perf Week0.00%
Market Cap494.35M Forward P/E- EPS next Y-0.15 Insider Trans-1.06% Shs Float406.48M Perf Month-3.97%
Income-52.56M PEG- EPS next Q-0.03 Inst Own23.55% Short Float3.54% Perf Quarter55.73%
Sales323.77M P/S1.53 EPS this Y39.88% Inst Trans-7.29% Short Ratio6.16 Perf Half Y17.48%
Book/sh1.35 P/B0.89 EPS next Y3.20% ROA-6.02% Short Interest14.40M Perf Year-33.52%
Cash/sh0.79 P/C1.54 EPS next 5Y38.90% ROE-9.21% 52W Range0.65 - 2.17 Perf YTD39.08%
Dividend Est.- P/FCF- EPS past 5Y-0.85% ROI-9.35% 52W High-44.24% Beta2.04
Dividend TTM- Quick Ratio1.74 Sales past 5Y22.37% Gross Margin56.18% 52W Low85.87% ATR (14)0.07
Dividend Ex-Date- Current Ratio2.69 EPS Y/Y TTM43.61% Oper. Margin-19.13% RSI (14)54.86 Volatility3.87% 5.48%
Employees365 Debt/Eq0.02 Sales Y/Y TTM-23.18% Profit Margin-16.23% Recom3.40 Target Price1.42
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-273.02% Payout- Rel Volume0.56 Prev Close1.19
Sales Surprise12.63% EPS Surprise-11.11% Sales Q/Q-26.30% EarningsFeb 29 BMO Avg Volume2.34M Price1.21
SMA200.10% SMA5013.27% SMA20017.80% Trades Volume1,299,061 Change1.68%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Underweight
Oct-25-23Downgrade Jefferies Buy → Hold $3 → $1
Jan-06-23Upgrade Jefferies Hold → Buy $1.30 → $3
May-06-22Downgrade JP Morgan Neutral → Underweight
May-05-22Downgrade SVB Leerink Outperform → Mkt Perform $10 → $3
May-05-22Downgrade H.C. Wainwright Buy → Neutral $10 → $3
May-04-22Downgrade Northland Capital Outperform → Market Perform
May-12-21Downgrade Goldman Neutral → Sell $6 → $5
Sep-29-20Resumed JP Morgan Neutral
Aug-26-20Initiated Piper Sandler Overweight $21
Feb-15-24 08:00AM
Jan-22-24 07:30AM
Jan-12-24 09:40AM
Jan-11-24 09:34AM
Jan-10-24 07:02PM
07:00AM Loading…
07:00AM
Dec-26-23 07:13PM
Dec-11-23 08:00AM
Dec-05-23 12:00PM
Nov-12-23 09:00AM
Nov-02-23 10:58AM
Nov-01-23 12:30PM
12:03PM
09:30AM
09:25AM
07:30AM Loading…
07:30AM
07:00AM
Oct-31-23 12:00PM
Oct-26-23 08:00AM
Oct-23-23 10:08AM
Oct-19-23 08:00AM
Sep-12-23 08:00AM
Aug-24-23 09:29AM
Aug-19-23 11:22AM
Aug-09-23 04:05PM
Aug-08-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:22AM
Aug-02-23 07:33AM
07:11AM
08:00AM Loading…
Jul-31-23 08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jul-25-23 04:05PM
Jul-20-23 08:00AM
Jul-19-23 12:58PM
11:19AM
Jul-18-23 04:16PM
04:15PM
Jul-05-23 11:43AM
Jun-21-23 09:00AM
Jun-08-23 11:07AM
Jun-01-23 04:30PM
06:00AM
May-23-23 09:50AM
May-12-23 11:00AM
May-03-23 02:00PM
01:47PM
07:41AM
07:00AM
May-02-23 01:32PM
Apr-19-23 08:00AM
Apr-17-23 07:00AM
Apr-13-23 10:18AM
Apr-12-23 09:18AM
Apr-04-23 03:53PM
08:00AM
Mar-16-23 08:00AM
Mar-06-23 04:05PM
09:37AM
08:00AM
Mar-05-23 10:21AM
Mar-03-23 11:09AM
Mar-02-23 01:23PM
11:44AM
05:55AM
Mar-01-23 11:02AM
11:00AM
07:00AM
Feb-28-23 11:11AM
10:39AM
10:38AM
08:00AM
Feb-27-23 04:29PM
08:00AM
07:15AM
Feb-24-23 11:52AM
Feb-22-23 04:50PM
08:00AM
Feb-21-23 08:30AM
08:00AM
Feb-20-23 01:00PM
Feb-17-23 09:03AM
07:30AM
Feb-16-23 04:05PM
12:34PM
09:44AM
Feb-15-23 04:29PM
Feb-14-23 05:09PM
09:55AM
Feb-13-23 07:47PM
09:40AM
08:00AM
08:00AM
Feb-09-23 05:27PM
08:00AM
Feb-07-23 04:35PM
Feb-06-23 08:00AM
Feb-03-23 05:16PM
Feb-02-23 04:30PM
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holt PatrickPresident and CEOJan 22Buy1.0914,42615,724314,426Jan 24 04:31 PM
Ketchum Steven BChief Scientific OfficerDec 12Sale0.7934,13126,963566,100Dec 14 06:35 PM
Holt PatrickPresident and CEOAug 16Buy1.04300,000312,315300,000Aug 16 07:51 PM